Learn more Veeva Systems (VEEV), headquartered in Pleasanton, California, is the premier provider of cloud-based software, ...

Moderna ‌surpassed Wall Street estimates for first-quarter revenue on Friday, helped by better-than-expected sales of its ...

Merck MRK reported an adjusted loss of $1.28 per share for the first quarter of 2026, which was narrower than the Zacks ...

Global pharmaceutical company Merck (NYSE:MRK) reported Q1 CY2026 results , with sales up 4.9% year on year to $16.29 billion ...

Q1 earnings beat lifts shares; 2026 guidance narrows as Keytruda grows, Gardasil declines and R&D jumps on deals.

Merck expects full-year earnings in the range of $5.04 to $5.16 per share, with revenue in the range of $65.8 billion to $67 billion. This story was generated by Automated Insights ( using data from ...

Merck is scheduled to report first-quarter earnings on April 30, during market hours, with analysts expecting a strong ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a collaboration with nine professional baseball teams and former professional baseball players to launch the ...

It is no secret that the pharmaceutical industry is facing a super-cliff of patent expirations, Merck & Co., Inc.

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Performing Dow Stocks So Far in 2026.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in ...